Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7515
Gene Symbol: XRCC1
XRCC1
0.010 AlteredExpression phenotype BEFREE In conclusion, this study showed modulations of hOGG1 and XRCC1 expression especially 1 day after elective surgery in patients undergoing PROP and ISO anaesthesia. 29669111 2018
Entrez Id: 65125
Gene Symbol: WNK1
WNK1
0.010 GeneticVariation phenotype BEFREE Hereditary sensory and autonomic neuropathy (HSAN) type II with WNK1/HSN2 gene mutation is a rare disease characterized by early-onset demyelination sensory loss and skin ulceration. 27765018 2016
Entrez Id: 7450
Gene Symbol: VWF
VWF
0.010 AlteredExpression phenotype BEFREE At T1, recipient groups showed comparable elevated levels of platelet factor 4 (PF4, indicating platelet activation), prothrombin fragment F1+2 and D-dimer (indicating coagulation activation) and Von Willebrand Factor (indicating endothelial activation) compared to the donors. 30011293 2018
Entrez Id: 30813
Gene Symbol: VSX1
VSX1
0.010 AlteredExpression phenotype BEFREE To measure the plasma concentrations of three endogenous opioid peptides and the levels of preproenkephalin (PPE) and preprodynorphin (PPD) mRNA in peripheral blood lymphocytes of patients during scheduled surgery performed under intravenous general anaesthesia combined with an epidural block. 24743873 2014
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.010 AlteredExpression phenotype BEFREE VEGF protein expression was increased in the hippocampus after isoflurane exposure, suggesting that inhalation anaesthesia induces hippocampal VEGF protein overexpression in aged rats. 31250275 2019
Entrez Id: 7408
Gene Symbol: VASP
VASP
0.010 Biomarker phenotype BEFREE Blood was drawn at induction of anaesthesia and platelet reactivity assessed by light transmittance aggregometry (LTA), vasodilator stimulated phosphoprotein (VASP) assay, Multiplate Analyzer and Innovance PFA-200. 29625498 2018
Entrez Id: 54600
Gene Symbol: UGT1A9
UGT1A9
0.010 GeneticVariation phenotype BEFREE The aim of our study was to verify the impact of genetic changes c.516G>T in the CYP2B6, c.98T>C in the UGT1A9 and c.1075A>C in the CYP2C9 genes on the individual propofol pharmacokinetic profile in the Polish patients undergoing general anaesthesia. 27826892 2017
Entrez Id: 79054
Gene Symbol: TRPM8
TRPM8
0.010 Biomarker phenotype BEFREE Thus, we propose TRPM8 as a new clinical target for diminishing common and serious complications of general anaesthesia. 23943870 2013
Entrez Id: 5987
Gene Symbol: TRIM27
TRIM27
0.010 Biomarker phenotype BEFREE Adult male C57BL/6 (n=111) and Ccr2<sup>RFP/+</sup>Cx3cr1<sup>GFP/+</sup> (n=54) mice were treated with MaR1 before undergoing anaesthesia and orthopaedic surgery. 30770053 2019
Entrez Id: 7202
Gene Symbol: TRI-AAT9-1
TRI-AAT9-1
0.010 GeneticVariation phenotype BEFREE The piglets were randomly allocated by weight and litter to 1 of 4 treatment groups: (i) sham castration (SHAM; n = 10); (ii) surgical castration with no anaesthetic intervention (CAST; n = 10); (iii) surgical castration with post-operative topical anaesthesia (TRI; n = 10); (iv) surgical castration with a pre-operative intra-testicular lignocaine hydrochloride injection (LIG; n = 10). 29140997 2017
Entrez Id: 7183
Gene Symbol: TRC-GCA24-1
TRC-GCA24-1
0.010 Biomarker phenotype BEFREE Patients undergoing radical resection for primary lung cancer were randomized to receive either combined epidural-general anaesthesia (Epi-GA) or general anaesthesia (GA) in an ongoing randomized controlled trial (ChiCTR-TRC-14004136). 29363103 2018
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.020 Biomarker phenotype BEFREE Multimodality approach was defined as using a combination of medical treatments (anti-TNFs ± immunomodulators ± antibiotics) along with surgical approach (examination under anaesthesia (EUA) ± seton drainage) at diagnosis of CD-pAF. 30226271 2018
Entrez Id: 7124
Gene Symbol: TNF
TNF
0.020 Biomarker phenotype BEFREE One hundred patients admitted for elective AAA repair had plasma levels of interleukin (IL) 1beta, IL-6, IL-10 and tumour necrosis factor (TNF) alpha measured at induction of anaesthesia and 24 h after operation. 12945076 2003
Entrez Id: 6863
Gene Symbol: TAC1
TAC1
0.010 Biomarker phenotype BEFREE Ketamine-xylazine anaesthesia and orofacial administration of substance P: A lethal combination in rats. 28162846 2017
Entrez Id: 10558
Gene Symbol: SPTLC1
SPTLC1
0.030 GeneticVariation phenotype BEFREE Hereditary sensory neuropathy type I (HSN I) is an axonal form of autosomal-dominant hereditary motor and sensory neuropathy distinguished by prominent sensory loss that leads to painless injuries. 21194679 2011
Entrez Id: 10558
Gene Symbol: SPTLC1
SPTLC1
0.030 Biomarker phenotype BEFREE Hereditary sensory neuropathy type I (HSN I) is a slowly progressive neurological disorder characterised by prominent predominantly distal sensory loss, autonomic disturbances, autosomal dominant inheritance, and juvenile or adulthood disease onset. 18348718 2008
Entrez Id: 10558
Gene Symbol: SPTLC1
SPTLC1
0.030 GeneticVariation phenotype BEFREE We performed linkage analysis with chromosomal markers representing the hereditary sensory neuropathy type I and Charcot-Marie-Tooth disease type 2B loci on an Italian family with a severe distal sensory loss leading to an ulcero-mutilating peripheral neuropathy. 11801401 2002
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.010 Biomarker phenotype BEFREE Five days after myocardial infarction, 18F-FDG PET was performed under anaesthesia with ketamine and xylazine (KX) to image the inflammatory response in the heart. 31835854 2019
Entrez Id: 6535
Gene Symbol: SLC6A8
SLC6A8
0.010 Biomarker phenotype BEFREE With respect to these findings both approaches-sedation only or general anaesthesia including CMV-can be safely implemented during CRT implantation. 29577341 2018
Entrez Id: 27352
Gene Symbol: SGSM3
SGSM3
0.020 Biomarker phenotype BEFREE However, with a similar level of anaesthesia effects and suitable parameters for mechanical ventilation, patients in the LMA group showed much more stability in the physiological indicators for inflammation and haemodynamics, including white blood cell count (ΔWBC) and percentage of neutrophil granulocytes (ΔNEU%) in the blood as well as heart rate (ΔHR) and mean arterial pressure (ΔMAP). 30069317 2018
Entrez Id: 27352
Gene Symbol: SGSM3
SGSM3
0.020 Biomarker phenotype BEFREE Following completion of treatment, MAP was determined in rats under anaesthesia via carotid artery cannulation. 28024836 2017
Entrez Id: 6445
Gene Symbol: SGCG
SGCG
0.010 Biomarker phenotype BEFREE In mammals, changes in the frequency spectrum of the electroencephalogram (EEG) recorded under light anaesthesia (the minimal anaesthesia model; MAM) have been shown to reliably indicate cerebral responses to noxious stimuli in a range of species. 29698446 2018
Entrez Id: 6419
Gene Symbol: SETMAR
SETMAR
0.010 Biomarker phenotype BEFREE Adult male C57BL/6 (n=111) and Ccr2<sup>RFP/+</sup>Cx3cr1<sup>GFP/+</sup> (n=54) mice were treated with MaR1 before undergoing anaesthesia and orthopaedic surgery. 30770053 2019
Entrez Id: 6285
Gene Symbol: S100B
S100B
0.020 AlteredExpression phenotype BEFREE Our results demonstrated that the primary outcome related to S100B level in the inhalation anaesthesia group was significantly lower than in the TIVA group after CPB and 24 hours postoperatively (weighted mean difference (WMD); 95% CI (CI): -0.41(-0.81 to -0.01), -0.32 (-0.59 to -0.05), respectively). 29025825 2017
Entrez Id: 6285
Gene Symbol: S100B
S100B
0.020 Biomarker phenotype BEFREE <b>Aim:</b> To clarify the impact of general anaesthesia on cognitive function and to study the possible effect of general anaesthesia on serum S100B, the marker of neuronal degeneration. 30590973 2019